"An Open-label, Multiple Ascending Dose Study to Determine the Maximum Tolerated Dose of R1530 in Patients With Advanced Solid Tumors."
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Maximum tolerated dose
Throughout study
No
Clinical Trials
Study Director
Hoffmann-La Roche
United States: Food and Drug Administration
NO18674
NCT00493155
October 2005
February 2009
Name | Location |
---|---|
Austin, Texas 78705 | |
Flint, Michigan 48532 | |
Boston, Massachusetts | |
Las Vegas, Nevada 89109 |